carrageenan and processed Eucheuma seaweed → has acceptable daily intake (ADI) → not specified
“The Committee also evaluated the risk posed by two food contaminants, with the aim of advising on risk management options for the purpose of public health protection.”
processed Eucheuma seaweed (E 407a) → is covered by → toxicological evaluation of carrageenan
“the safety of processed Eucheuma seaweed was sufficiently covered by the toxicological evaluation of carrageenan;”
carrageenan (E 407) → does not raise → concern with respect to carcinogenicity
“there was no concern with respect to the carcinogenicity of carrageenan;”
carrageenan (E 407) → has → no-observed-adverse-effect level (NOAEL)
value: 7,500 mg/kg bw per dayspecies: ratsstudy_type: chronic toxicity study
“no adverse effects have been detected in chronic toxicity studies with carrageenan in rats up to 7,500 mg/kg bw per day, the highest dose tested;”
carrageenan (E 407) → does not raise → concern with respect to genotoxicity
“carrageenan and processed Eucheuma seaweed did not raise a concern with respect to genotoxicity;”
carrageenan (E 407) → has → no-observed-adverse-effect level (NOAEL)
value: 3,400-3,900 mg/kg body weight (bw) per dayspecies: ratsstudy_type: subchronic toxicity study
“in a subchronic toxicity study performed with carrageenan almost complying with the EU specification for E 407 in rats, the no-observed-adverse-effect level (NOAEL) was 3,400-3,900 mg/kg body weight (bw) per day, the highest dose tested;”